Abstract
Manganese oxide supported on alumina and zirconia has been prepared by precipitation-impregnation method. The materials have been characterized by FT-IR, P-XRD, BET, TPD-NH3, TGA, SEM and TEM techniques for their textural properties. The catalytic activity of these materials has been explored in the synthesis of dihydropyrimidinones via.,Biginelli reaction. A rod like morphology is observed for zirconia containing 5% manganese oxide. These materials exhibited good catalytic activity in terms of isolated yield (>97%) and selectivity (100%) for the synthesis of dihydropyrimidinones. Acidity of the catalysts and the tetragonal phase of zirconia were found to play an important role in catalyzing this reaction. The catalyst with 5%Mn/ZrO2 exhibited distinctly different catalytic activity. The catalyst is reusable without losing its activity upto 5 cycles.
Keywords: Biginelli reaction, dihydropyrimidinones, manganese oxide on alumina/zirconia, role of acidity, solvent free synthesis.
Current Catalysis
Title:Catalytic Activity of Manganese Oxide Anchored on to Alumina and Zirconia for the Synthesis of Dihydropyrimidinones: Role of Acidity, Crystal Phase and Morphology
Volume: 3 Issue: 1
Author(s): Mahadevaiah Rekha, Hagalahalli N. Hareesh, Nagaraju Kathyayini and Narasimaiah Nagaraju
Affiliation:
Keywords: Biginelli reaction, dihydropyrimidinones, manganese oxide on alumina/zirconia, role of acidity, solvent free synthesis.
Abstract: Manganese oxide supported on alumina and zirconia has been prepared by precipitation-impregnation method. The materials have been characterized by FT-IR, P-XRD, BET, TPD-NH3, TGA, SEM and TEM techniques for their textural properties. The catalytic activity of these materials has been explored in the synthesis of dihydropyrimidinones via.,Biginelli reaction. A rod like morphology is observed for zirconia containing 5% manganese oxide. These materials exhibited good catalytic activity in terms of isolated yield (>97%) and selectivity (100%) for the synthesis of dihydropyrimidinones. Acidity of the catalysts and the tetragonal phase of zirconia were found to play an important role in catalyzing this reaction. The catalyst with 5%Mn/ZrO2 exhibited distinctly different catalytic activity. The catalyst is reusable without losing its activity upto 5 cycles.
Export Options
About this article
Cite this article as:
Rekha Mahadevaiah, Hareesh N. Hagalahalli, Kathyayini Nagaraju and Nagaraju Narasimaiah, Catalytic Activity of Manganese Oxide Anchored on to Alumina and Zirconia for the Synthesis of Dihydropyrimidinones: Role of Acidity, Crystal Phase and Morphology, Current Catalysis 2014; 3 (1) . https://dx.doi.org/10.2174/2211544703999140130115808
DOI https://dx.doi.org/10.2174/2211544703999140130115808 |
Print ISSN 2211-5447 |
Publisher Name Bentham Science Publisher |
Online ISSN 2211-5455 |
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
- Announcements
Related Articles
-
Growth Factors and Chemokines: A Comparative Functional Approach Between Invertebrates and Vertebrates
Current Medicinal Chemistry Chemical Metabolic Inhibitors for the Treatment of Blood-Borne Cancers
Anti-Cancer Agents in Medicinal Chemistry Pathologic Findings of Autoimmune Pancreatitis and IgG4-Related Disease
Current Immunology Reviews (Discontinued) Intracellular Restriction Factors In Mammalian Cells - An Ancient Defense System Finds A Modern Foe
Current HIV Research Orexins and Gastrointestinal Functions
Current Protein & Peptide Science Tumor Growth is Stimulated by Muscarinic Receptor Agonism: Role of Autoantibodies in Breast Cancer Patients
Immunology, Endocrine & Metabolic Agents in Medicinal Chemistry (Discontinued) Endothelial Dysfunction in Hyperglycemia as a Trigger of Atherosclerosis
Current Diabetes Reviews The Quest to Repair the Damaged Spinal Cord
Recent Patents on CNS Drug Discovery (Discontinued) CNS Immune Surveillance and Neuroinflammation: Endocannabinoids Keep Control
Current Pharmaceutical Design Ketamine for Chronic Pain and Treatment Resistant Depression: A Mechanistic Hypothesis
Current Drug Therapy Interleukin-21 (IL-21) Controls Inflammatory Pathways in the Gut
Endocrine, Metabolic & Immune Disorders - Drug Targets Gender Differences in Metabolic Syndrome – A Key Research Issue
Endocrine, Metabolic & Immune Disorders - Drug Targets Osteogenic Differentiation Factors of Multipotent Mesenchymal Stromal Cells in the Current Understanding
Current Pharmaceutical Design The Anti-Inflammatory Role of Minocycline in Alzheimer´s Disease
Current Alzheimer Research Medicinal Value and Potential Therapeutic Mechanisms of Gynostemma pentaphyllum (Thunb.) Makino and Its Derivatives: An Overview
Current Topics in Medicinal Chemistry β-Sheet Breakers for Alzheimers Disease Therapy
Current Drug Targets Advancing Drug Therapy for Brain Tumours: A Current Review of the Pro-inflammatory Peptide Substance P and its Antagonists as Anti-cancer Agents
Recent Patents on CNS Drug Discovery (Discontinued) Development of Folate-Conjugated PEGylated Poly (d,l-lactide-co-glycolide) Nanoparticulate Carrier for Docetaxel
Current Nanoscience The Utility of Antiemetics in the Prevention and Treatment of Postoperative Nausea and Vomiting in Patients Scheduled for Laparoscopic Cholecystectomy
Current Pharmaceutical Design Sofosbuvir: Really Meets the Unmet Needs for Hepatitis C Treatment?
Infectious Disorders - Drug Targets